Momenta Pharmaceuticals Inc [MNTA]
$12.50 0.04 (0.32%)

MNTA Profile

Sector Health Care
Industry Drug Manufacturers
Market Cap 1.18 Billion
MNTA Description

Momenta is a biotechnology company focused on the characterization and development of innovative drugs in autoimmune diseases. Its legacy business includes complex generic versions of MS drug Copaxone and anticoagulant Lovenox, and it receives royalties for these products through a partnership with Novartis. While biosimilar versions of Humira and Eylea are in the pipeline, Momenta terminated future development in generics/biosimilars in 2018. Several innovative drugs, including M281, M254, and M230, are in development to treat rare autoimmune diseases.

Visit Website

MNTA Earnings

EPS -0.46 P/E Ratio 0.00
Previous Earnings Fri, Feb 22, 2019
Latest Earnings Thu, May 2, 2019 (48 days ago) -10.15%

MNTA Dividend

Yield --
Ex-Date --
Pay Date --
History --

MNTA Charts

52 Week Range
Dec 24, 2018
Jul 25, 2018

Symbol Price Day % YTD %
MNTA $12.50 0.32% 10.62%
Symbol Surfing

How can we make Symbol Surfing better?

Information is provided "as is" and solely for informational purposes, not for trading purposes or advice, and may be delayed.

©2019 Symbol Surfing All Rights Reserved.

Cookies Policy | Terms Of Service | Privacy Policy